Construction of a Prognostic Immune-Related LncRNA Risk Model for Gastric Cancer

Figure 5

Nomograms for patients with gastric cancer. (a) The 1-, 3-, and 5-year overall survival nomogram. (b) The 1-, 3-, and 5-year disease-free survival nomogram. The calibration curves for predicting the (c–e) 1-, 3-, and 5-year overall survival and (f–h) 1-, 3-, and 5-year disease-free survival rates by nomogram prediction and actual observation in patients with gastric cancer.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)